ACERUS OTC Stock Valuation

ASPCF -  USA Stock  

USD 0.03  0.0018  6.38%

What is the value of ACERUS PHARMACEUTICALS today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as ACERUS PHARMACEUTICALS, is its stock price multiplied by the total number of shares outstanding, calculating ACERUS PHARMACEUTICALS's enterprise value requires a different approach. It uses ACERUS PHARMACEUTICALS's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
ACERUS PHARMACEUTICALS seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of ACERUS PHARMACEUTICALS from evaluating the entity fundamentals such as price to sales of 27.30 X, and Shares Outstanding of 1.54 B as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we favor purchasing undervalued instruments and exiting overvalued instruments since, at some future date, asset prices and their ongoing real values will blend.

ACERUS Valuation 

 
Refresh
ACERUS PHARMACEUTICALS Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as ACERUS PHARMACEUTICALS's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Overvalued
Today
0.03
16th of October 2021
Share
Please note that ACERUS PHARMACEUTICALS's price fluctuation is out of control at this time. Calculation of the real value of ACERUS PHARMACEUTICALS is based on 3 months time horizon. Increasing ACERUS PHARMACEUTICALS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for ACERUS PHARMACEUTICALS CORP is useful when determining the fair value of the ACERUS otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of ACERUS PHARMACEUTICALS. Since ACERUS PHARMACEUTICALS is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ACERUS OTC Stock. However, ACERUS PHARMACEUTICALS's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
0.026922
Real Value
11.39
Upside
Estimating the potential upside or downside of ACERUS PHARMACEUTICALS CORP helps investors to forecast how ACERUS otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ACERUS PHARMACEUTICALS more accurately as focusing exclusively on ACERUS PHARMACEUTICALS's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimated ValueHigh
0.000.0311.39
Details

ACERUS PHARMACEUTICALS Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining ACERUS PHARMACEUTICALS's current stock value. Our valuation model uses many indicators to compare ACERUS PHARMACEUTICALS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ACERUS PHARMACEUTICALS competition to find correlations between indicators driving ACERUS PHARMACEUTICALS's intrinsic value. More Info.
ACERUS PHARMACEUTICALS CORP is rated second in beta category among related companies. It is number one stock in price to book category among related companies fabricating about  17.10  of Price to Book per Beta.

About ACERUS PHARMACEUTICALS Valuation

The equity valuation mechanism determines the current worth of ACERUS PHARMACEUTICALS CORP on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of ACERUS PHARMACEUTICALS CORP. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ACERUS PHARMACEUTICALS based exclusively on its fundamental and basic technical indicators. By analyzing ACERUS PHARMACEUTICALS's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ACERUS PHARMACEUTICALS's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ACERUS PHARMACEUTICALS. We calculate exposure to ACERUS PHARMACEUTICALS's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ACERUS PHARMACEUTICALS's related companies.
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for mens and womens health. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada. ACERUS PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 10 people.

ACERUS PHARMACEUTICALS Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as ACERUS PHARMACEUTICALS does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio0.35
Revenue Growth219.30%
Enterprise Value To Ebitda-2.61
Enterprise Value To Revenue42.64
Please continue to Trending Equities. Note that the ACERUS PHARMACEUTICALS information on this page should be used as a complementary analysis to other ACERUS PHARMACEUTICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for ACERUS OTC Stock analysis

When running ACERUS PHARMACEUTICALS price analysis, check to measure ACERUS PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACERUS PHARMACEUTICALS is operating at the current time. Most of ACERUS PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of ACERUS PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ACERUS PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of ACERUS PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
The market value of ACERUS PHARMACEUTICALS is measured differently than its book value, which is the value of ACERUS that is recorded on the company's balance sheet. Investors also form their own opinion of ACERUS PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is ACERUS PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACERUS PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect ACERUS PHARMACEUTICALS underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACERUS PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine ACERUS PHARMACEUTICALS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACERUS PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.